Diaxxo AG is a startup that focuses on PCR diagnostics with the vision of making precise and reliable diagnostics accessible to everyone, anywhere. The company aims to revolutionize healthcare by addressing current challenges in diagnostic procedures. Founded in 2020, Diaxxo AG strives to offer high-quality, fast, and affordable RT-PCR testing. The startup operates within the healthcare, IT, and medical devices industries, providing innovative solutions to transform the healthcare landscape.
There is no investment information
No recent news or press coverage available for Diaxxo AG.